NCT04679883

Phase 2 Clinical Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

A Phase 2 Multicenter, Randomized, Double-blinded, Placebo-controlled Trial to Evaluate the Efficacy and Safety of GLH8NDE in Patients With Dry Eye Disease

• Status: Unknown
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 99 (estimated)
• Sponsor: GL Pharm Tech Corporation · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This study is a randomized, double-blind, placebo-controlled phase 2 clinical trial to evaluate the efficacy and safety of GLH8NDE in patients with Dry Eye Disease.

Conditions

• Dry Eye Syndromes

Interventions

Type	Name	Description
DRUG	5% GLH8NDE	5% GLH8NDE as eye drops
DRUG	Placebo	Placebo as eye drops

Timeline

• Start date: 2021-04-01
• Primary completion: 2022-01-30
• Completion: 2022-04-30
• First posted: 2020-12-22
• Last updated: 2021-01-06

Locations

1 site across 1 country: South Korea